ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model.
Daly O, Mahiny AJ, Majeski S, McClintock K, Reichert J, Boros G, Szabó GT, Reinholz J, Schreiner P, Reid S, Lam K, Lepper M, Adler M, Meffen T, Heyes J, Karikó K, Lutwyche P, Vlatkovic I.
Daly O, et al. Among authors: lutwyche p.
Biomedicines. 2023 Jun 16;11(6):1735. doi: 10.3390/biomedicines11061735.
Biomedicines. 2023.
PMID: 37371829
Free PMC article.